BRPI0814115A2 - Composição farmacêutica compreendendo composto de 11-deóxi-prostaglandina e método para estabilizar o composto - Google Patents

Composição farmacêutica compreendendo composto de 11-deóxi-prostaglandina e método para estabilizar o composto

Info

Publication number: BRPI0814115A2
Authority: BR; Brazil
Prior art keywords: compound; dexy; prostaglandine; pharmaceutical composition; stabilize
Prior art date: 2007-07-19

Application number

BRPI0814115-0A2A

Other languages

English (en)

Inventor

Yasuhiro Harada

Junichi Kawasaki

Yoshie Nishimura

Ryuji Ueno

Original Assignee

R Tech Ueno Ltd

Sucampo Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-07-19

Filing date

2008-07-16

Publication date

2015-02-03

2008-07-16 Application filed by R Tech Ueno Ltd, Sucampo Ag filed Critical R Tech Ueno Ltd

2015-02-03 Publication of BRPI0814115A2 publication Critical patent/BRPI0814115A2/pt

2019-04-02 Publication of BRPI0814115B1 publication Critical patent/BRPI0814115B1/pt

2021-05-25 Publication of BRPI0814115B8 publication Critical patent/BRPI0814115B8/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

BRPI0814115A 2007-07-19 2008-07-16 composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto BRPI0814115B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US92994807P	2007-07-19	2007-07-19
US60/929,948		2007-07-19
PCT/JP2008/063222 WO2009011449A2 (en)	2007-07-19	2008-07-16	Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound

Publications (3)

Publication Number	Publication Date
BRPI0814115A2 true BRPI0814115A2 (pt)	2015-02-03
BRPI0814115B1 BRPI0814115B1 (pt)	2019-04-02
BRPI0814115B8 BRPI0814115B8 (pt)	2021-05-25

Family

ID=39720491

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0814115A BRPI0814115B8 (pt)	2007-07-19	2008-07-16	composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto

Country Status (14)

Country	Link
US (2)	US8969324B2 (pt)
EP (2)	EP2327398A3 (pt)
JP (2)	JP5390519B2 (pt)
KR (1)	KR101485212B1 (pt)
CN (2)	CN101808623B (pt)
AU (1)	AU2008276840B2 (pt)
BR (1)	BRPI0814115B8 (pt)
CA (1)	CA2691995C (pt)
IL (1)	IL203064B (pt)
MX (1)	MX339727B (pt)
NZ (2)	NZ595270A (pt)
RU (3)	RU2506072C2 (pt)
TW (2)	TWI552772B (pt)
WO (1)	WO2009011449A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN104983712A (zh)	2006-01-24	2015-10-21	株式会社·R-技术上野	软明胶胶囊制剂
AU2012293157A1 (en) *	2011-08-05	2014-03-13	Sucampo Ag	Method for treating schizophrenia
WO2014159679A1 (en)	2013-03-12	2014-10-02	The United States Of America, As Represented By The Secretary, Department Of Health & Human Services	Methods for using lubiprostone to absorb fluid from the subretinal space
JP6580414B2 (ja) *	2015-08-07	2019-09-25	小林製薬株式会社	生薬末含有錠剤
US10716544B2 (en)	2015-10-08	2020-07-21	Zmk Medical Technologies Inc.	System for 3D multi-parametric ultrasound imaging
CN108619107A (zh) *	2018-05-28	2018-10-09	青海制药厂有限公司	一种含鲁比前列酮的软胶囊及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
LU36479A1 (pt) *	1958-02-12
JPS5350141A (en) *	1976-10-18	1978-05-08	Ono Pharmaceut Co Ltd	Stabilization of prostaglandin and prostaglandin analogues
US4310543A (en) *	1980-10-09	1982-01-12	Hoffmann-La Roche Inc.	Prostaglandin compositions
US4301175A (en) *	1980-12-29	1981-11-17	The Upjohn Company	E-Type prostaglandin compositions
US4431833A (en) *	1982-12-27	1984-02-14	American Cyanamid Company	Prostaglandin and hydroxylated fatty acid ester formulations
KR920007569B1 (ko) *	1984-11-30	1992-09-07	쥬우가이 세이야꾸 가부시끼가이샤	프로스타글란딘 e 유도체의 안정한 제제의 제조방법
US5166174A (en) *	1987-01-28	1992-11-24	K.K. Ueno Seiyaku Oyo Kenkyujo	Prostaglandins E and anti-ulcers containing same
US6183466B1 (en) *	1998-08-21	2001-02-06	Alza Corporation	Dosage form comprising a capsule
PT1426361E (pt) *	1999-10-15	2008-10-08	Sucampo Ag	Nova composição contendo um composto bicíclico e um glicérido
ATE387191T1 (de) *	2002-04-25	2008-03-15	Banner Pharmacaps Inc	Kaubare weichkapsel
FR2850275B1 (fr) *	2003-01-24	2005-04-08	Scherer Technologies Inc R P	Capsules molles a macher contenant une substance active a gout masque
JP2007523904A (ja) *	2004-02-17	2007-08-23	シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト	被覆された、球状のシームレス型充填カプセル
TWI384988B (zh) *	2005-01-27	2013-02-11	Sucampo Ag	處理中樞神經系統失常用之組成物
WO2006093348A2 (en) *	2005-03-04	2006-09-08	Sucampo Ag	Method and composition for treating peripheral vascular diseases
CN104983712A (zh)	2006-01-24	2015-10-21	株式会社·R-技术上野	软明胶胶囊制剂

2008
- 2008-07-16 KR KR1020107003612A patent/KR101485212B1/ko not_active Expired - Fee Related
- 2008-07-16 JP JP2010516705A patent/JP5390519B2/ja not_active Expired - Fee Related
- 2008-07-16 NZ NZ59527008A patent/NZ595270A/xx not_active IP Right Cessation
- 2008-07-16 US US12/174,230 patent/US8969324B2/en active Active
- 2008-07-16 EP EP20110158821 patent/EP2327398A3/en not_active Withdrawn
- 2008-07-16 BR BRPI0814115A patent/BRPI0814115B8/pt active IP Right Grant
- 2008-07-16 MX MX2010000693A patent/MX339727B/es active IP Right Grant
- 2008-07-16 RU RU2010105847/15A patent/RU2506072C2/ru active
- 2008-07-16 WO PCT/JP2008/063222 patent/WO2009011449A2/en not_active Ceased
- 2008-07-16 EP EP08778342.9A patent/EP2178516B1/en not_active Not-in-force
- 2008-07-16 CN CN2008800250368A patent/CN101808623B/zh not_active Expired - Fee Related
- 2008-07-16 CA CA2691995A patent/CA2691995C/en active Active
- 2008-07-16 AU AU2008276840A patent/AU2008276840B2/en not_active Ceased
- 2008-07-16 CN CN2013102926965A patent/CN103393618A/zh active Pending
- 2008-07-16 NZ NZ583203A patent/NZ583203A/en not_active IP Right Cessation
- 2008-07-17 TW TW103122235A patent/TWI552772B/zh not_active IP Right Cessation
- 2008-07-17 TW TW97127090A patent/TWI446912B/zh not_active IP Right Cessation
2009
- 2009-12-31 IL IL203064A patent/IL203064B/en active IP Right Grant
2013
- 2013-07-26 RU RU2013135403A patent/RU2651471C2/ru active
- 2013-10-09 JP JP2013211759A patent/JP2014001247A/ja active Pending
2015
- 2015-01-06 US US14/590,067 patent/US9254326B2/en not_active Expired - Fee Related
2018
- 2018-04-12 RU RU2018113296A patent/RU2018113296A/ru not_active Application Discontinuation

Also Published As

Publication number	Publication date
RU2651471C2 (ru)	2018-04-19
TW201436824A (zh)	2014-10-01
AU2008276840B2 (en)	2013-10-03
EP2327398A2 (en)	2011-06-01
RU2506072C2 (ru)	2014-02-10
US8969324B2 (en)	2015-03-03
KR20100053563A (ko)	2010-05-20
RU2010105847A (ru)	2011-08-27
US20150126609A1 (en)	2015-05-07
IL203064B (en)	2018-02-28
CN103393618A (zh)	2013-11-20
CA2691995C (en)	2016-04-26
MX2010000693A (es)	2010-06-01
EP2327398A3 (en)	2014-05-21
BRPI0814115B1 (pt)	2019-04-02
JP2014001247A (ja)	2014-01-09
EP2178516A2 (en)	2010-04-28
TWI552772B (zh)	2016-10-11
NZ583203A (en)	2011-10-28
TW200911273A (en)	2009-03-16
US9254326B2 (en)	2016-02-09
JP2010533707A (ja)	2010-10-28
RU2018113296A (ru)	2019-10-14
CN101808623B (zh)	2013-08-14
BRPI0814115B8 (pt)	2021-05-25
AU2008276840A1 (en)	2009-01-22
WO2009011449A3 (en)	2010-04-29
KR101485212B1 (ko)	2015-01-22
US20090022787A1 (en)	2009-01-22
JP5390519B2 (ja)	2014-01-15
WO2009011449A2 (en)	2009-01-22
RU2013135403A (ru)	2015-02-10
EP2178516B1 (en)	2015-09-09
MX339727B (es)	2016-06-06
CA2691995A1 (en)	2009-01-22
CN101808623A (zh)	2010-08-18
NZ595270A (en)	2013-04-26
TWI446912B (zh)	2014-08-01

Publication	Publication Date	Title
LTC2140867I2 (lt)	2018-11-12	Farmacinė kompozicija
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BRPI0919466A2 (pt)	2015-12-01	composição farmacêutica para liberação modificada
BRPI0819218A2 (pt)	2015-05-05	Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI0721651A2 (pt)	2014-04-01	Composição farmacêutica
BRPI0815407A2 (pt)	2014-09-30	Composições e métodos para controlar nematódeos
BRPI0918971A2 (pt)	2015-12-01	tienopirimidinas para composições farmacêuticas
BRPI0715712A2 (pt)	2014-06-24	Composição farmacêutica
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
BRPI0719393A2 (pt)	2015-03-31	Composição farmacêutica
BRPI0911685A2 (pt)	2015-10-13	composto, método para o tratamento de uma doença, uso de um composto, composição farmacêutica, e, kit
DK2120884T3 (da)	2011-02-07	Farmaceutisk sammensætning
BRPI0819232A2 (pt)	2016-11-01	composto heterocíclico e composição farmacêutica do mesmo
BRPI0809661A2 (pt)	2014-10-14	Composição farmacêutica estabilizada contendo pregabalina
BRPI0720234A2 (pt)	2013-12-24	Composição farmacêutica
BRPI0716445A2 (pt)	2013-09-17	composiÇço farmacÊutica
BRPI0908132A2 (pt)	2015-08-04	Composto de benzodiazepina e composição farmacêutica
DK2285413T3 (da)	2012-08-27	Farmaceutisk sammensætning
BRPI0814821A2 (pt)	2015-02-03	Composto, composição farmacêutica, e, processo para preparar um composto
BRPI0909885A2 (pt)	2015-10-27	composição decorativa e método para sua utilização
PT2209464E (pt)	2014-09-05	Composição farmacêutica antimalárica
BRPI0921313A2 (pt)	2015-12-29	composição farmaucêutica
BRPI0814043A2 (pt)	2017-05-16	composição farmacêutica para aplicação tópica de compostos pouco solúveis
BRPI0917562A2 (pt)	2017-06-20	composições farmacêuticas e métodos para estabilizar as mesmas

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-08	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-05-29	B06I	Publication of requirement cancelled [chapter 6.9 patent gazette]	Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2467 DE 17/04/2018 POR TER SIDO INDEVIDA.
2018-06-12	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2018-10-30	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-02-12	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-04-02	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/04/2019, OBSERVADAS AS CONDICOES LEGAIS
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/07/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF